This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes
BMC Cancer Open Access 13 May 2021
-
Identification of a selective inhibitor of IDH2/R140Q enzyme that induces cellular differentiation in leukemia cells
Cell Communication and Signaling Open Access 03 April 2020
-
Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers
Scientific Reports Open Access 14 November 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360: 765–773.
Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009; 361: 1058–1066.
Chou WC, Hou HA, Chen CY, Tang JL, Yao M, Tsay W et al. Distinct clinical and biological characteristics in adult acute myeloid leukemia bearing isocitrate dehydrogenase 1 (IDH1) mutation. Blood 2010. e-pub ahead of print 22 January 2010; doi: 10.1182/blood-2009-11-253070.
Schnittger S, Haferlach C, Ulke M, Kaya L, Weiss T, Kern W et al. IDH1 mutations are detected in 9.3% of all AML and are strongly associated with intermediate risk karyotype and unfavourable prognosis: a study of 999 patients. Blood 2009; 114 (abstract LBA-3).
Xu X, Zhao J, Xu Z, Peng B, Huang Q, Arnold E et al. Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity. J Biol Chem 2004; 279: 33946–33957.
Gross S, Cairns RA, Minden MD, Driggers EM, Bittinger MA, Jang HG et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med 2010; 207: 339–344.
Green A, Beer P . Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms. N Engl J Med 2010; 362: 369–370.
Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Massé A et al. Mutation in TET2 in myeloid cancers. N Engl J Med 2009; 360: 2289–2301.
Acknowledgements
We thank Professor D Bouscary, Dr J Tamburini and Dr S Park for including the patients. This work was supported by INSERM, INCa and the DRRC (Direction régionale de la Recherche Clinique AP-HP).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Kosmider, O., Gelsi-Boyer, V., Slama, L. et al. Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms. Leukemia 24, 1094–1096 (2010). https://doi.org/10.1038/leu.2010.52
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.52
This article is cited by
-
A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome
Journal of Cancer Research and Clinical Oncology (2023)
-
Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes
BMC Cancer (2021)
-
Mitochondrial matrix protein C14orf159 attenuates colorectal cancer metastasis by suppressing Wnt/β-catenin signalling
British Journal of Cancer (2021)
-
Identification of a selective inhibitor of IDH2/R140Q enzyme that induces cellular differentiation in leukemia cells
Cell Communication and Signaling (2020)
-
Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers
Scientific Reports (2019)